Figure 1From: Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients Disease-free survival and Overall survival. A. Disease-free survival and B. Overall survival in the HER2-positive group.Back to article page